<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38520748</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Print">2052-0573</ISSN><JournalIssue CitedMedium="Print"><Volume>2024</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Endocrinology, diabetes &amp; metabolism case reports</Title><ISOAbbreviation>Endocrinol Diabetes Metab Case Rep</ISOAbbreviation></Journal><ArticleTitle>Use of testosterone replacement therapy to treat long-COVID-related hypogonadism.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">23-0097</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1530/EDM-23-0097</ELocationID><Abstract><AbstractText Label="SUMMARY" NlmCategory="UNASSIGNED">Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can impair pituitary-gonadal axis and a higher prevalence of hypogonadism in post-coronavirus disease 2019 (COVID-19) patients compared with the general population has been highlighted. Here we report the first case of a patient affected with a long-COVID syndrome leading to hypogonadism and treated with testosterone replacement therapy (TRT) and its effects on clinical and quality of life (QoL) outcomes. We encountered a 62-year-old man who had been diagnosed with hypogonadotropic hypogonadism about 2 months after recovery from COVID-19 underwent a complete physical examination, general and hormonal blood tests, and self-reported questionnaires administration before and after starting TRT. Following the TRT, both serum testosterone level and hypogonadism-related symptoms were improved, but poor effects occurred on general and neuropsychiatric symptoms and QoL. Therefore, hypogonadism does not appear to be the cause of neurocognitive symptoms, but rather a part of the long-COVID syndrome; as a consequence, starting TRT can improve the hypogonadism-related symptoms without clear benefits on general clinical condition and QoL, which are probably related to the long-COVID itself. Longer follow-up might clarify whether post-COVID hypogonadism is a transient condition that can revert as the patient recovers from long-COVID syndrome.</AbstractText><AbstractText Label="LEARNING POINTS" NlmCategory="UNASSIGNED">Hypogonadism is more prevalent in post-COVID-19 patients compared with the general population. In these patients, hypogonadism may be part of long-COVID syndrome, and it is still unclear whether it is a transient condition or a permanent impairment of gonadal function. Testosterone replacement therapy has positive effects on hypogonadism-related clinic without clear benefits on general symptomatology and quality of life, which are more likely related to the long-COVID itself.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Amodeo</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0000-0224-8104</Identifier><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Persani</LastName><ForeName>Luca</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-2068-9581</Identifier><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonomi</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5454-6074</Identifier><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cangiano</LastName><ForeName>Biagio</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Endocrinol Diabetes Metab Case Rep</MedlineTA><NlmUniqueID>101618943</NlmUniqueID><ISSNLinking>2052-0573</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors declare that they have no competing interests. Marco Bonomi is on the editorial board of <i>Endocrinology, Diabetes &amp; Metabolism Case Reports</i>. He was not involved in the review or editorial process for this paper, on which he is listed as an author.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>24</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>24</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>23</Day><Hour>19</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38520748</ArticleId><ArticleId IdType="pmc">PMC10959025</ArticleId><ArticleId IdType="doi">10.1530/EDM-23-0097</ArticleId><ArticleId IdType="pii">23-0097</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. &amp; WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet. Infectious Diseases 202222e102&#x2013;e107. (10.1016/S1473-3099(2100703-9)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(2100703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto Y Otsuka Y Sunada N Tokumasu K Nakano Y Honda H Sakurada Y Hagiya H Hanayama Y &amp; Otsuka F. Detection of male hypogonadism in patients with post COVID-19 condition. Journal of Clinical Medicine 202211. (10.3390/jcm11071955)</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11071955</ArticleId><ArticleId IdType="pmc">PMC8999458</ArticleId><ArticleId IdType="pubmed">35407562</ArticleId></ArticleIdList></Reference><Reference><Citation>Corona G, Vena W, Pizzocaro A, Pallotti F, Paoli D, Rastrelli G, Baldi E, Cilloni N, Gacci M, Semeraro F, et al.Andrological effects of SARS-Cov-2 infection: a systematic review and meta-analysis. Journal of Endocrinological Investigation 2022452207&#x2013;2219. (10.1007/s40618-022-01801-x)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-022-01801-x</ArticleId><ArticleId IdType="pmc">PMC9080963</ArticleId><ArticleId IdType="pubmed">35527294</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Perez O, Merino E, Alfayate R, Torregrosa ME, Andres M, Leon-Ramirez JM, Boix V, Gil J, Pico A. &amp; COVID19-ALC Research Group. Male pituitary-gonadal axis dysfunction in post-acute COVID-19 syndrome-Prevalence and associated factors: a Mediterranean case series. Clinical Endocrinology 202296353&#x2013;362. (10.1111/cen.14537)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen.14537</ArticleId><ArticleId IdType="pmc">PMC8444731</ArticleId><ArticleId IdType="pubmed">34160836</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhindsa S, Champion C, Deol E, Lui M, Campbell R, Newman J, Yeggalam A, Nadella S, Ahir V, Shrestha E, et al.Association of male hypogonadism with risk of hospitalization for COVID-19. JAMA Network Open 20225e2229747. (10.1001/jamanetworkopen.2022.29747)</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.29747</ArticleId><ArticleId IdType="pmc">PMC9440397</ArticleId><ArticleId IdType="pubmed">36053534</ArticleId></ArticleIdList></Reference><Reference><Citation>Salonia A, Pontillo M, Capogrosso P, Gregori S, Carenzi C, Ferrara AM, Rowe I, Boeri L, Larcher A, Ramirez GA, et al.Testosterone in males with COVID-19: a 7-month cohort study. Andrology 20221034&#x2013;41. (10.1111/andr.13097)</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/andr.13097</ArticleId><ArticleId IdType="pmc">PMC8444879</ArticleId><ArticleId IdType="pubmed">34409772</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansone A, Mollaioli D, Limoncin E, Ciocca G, B&#x1eaf;c NH, Cao TN, Hou G, Yuan J, Zitzmann M, Giraldi A, et al.The sexual long COVID (SLC): erectile dysfunction as a biomarker of systemic complications for COVID-19 long haulers. Sexual Medicine Reviews 202210271&#x2013;285. (10.1016/j.sxmr.2021.11.001)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sxmr.2021.11.001</ArticleId><ArticleId IdType="pmc">PMC8604714</ArticleId><ArticleId IdType="pubmed">34933829</ArticleId></ArticleIdList></Reference><Reference><Citation>Ata B Vermeulen N Mocanu E Gianaroli L Lundin K Rautakallio-Hokkanen S Tapanainen JS &amp; Veiga A. SARS-CoV-2, fertility and assisted reproduction. Human Reproduction Update 202329177&#x2013;196. (10.1093/humupd/dmac037)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humupd/dmac037</ArticleId><ArticleId IdType="pmc">PMC9976972</ArticleId><ArticleId IdType="pubmed">36374645</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadihasanoglu M Aktas S Yardimci E Aral H &amp; Kadioglu A. SARS-CoV-2 pneumonia affects male reproductive hormone levels: a prospective, cohort study. Journal of Sexual Medicine 202118256&#x2013;264. (10.1016/j.jsxm.2020.11.007)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsxm.2020.11.007</ArticleId><ArticleId IdType="pmc">PMC7691132</ArticleId><ArticleId IdType="pubmed">33468445</ArticleId></ArticleIdList></Reference><Reference><Citation>Tufan A Avano&#x11f;lu G&#xfc;ler A &amp; Matucci-Cerinic M. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turkish Journal of Medical Sciences 202050620&#x2013;632. (10.3906/sag-2004-168)</Citation><ArticleIdList><ArticleId IdType="doi">10.3906/sag-2004-168</ArticleId><ArticleId IdType="pmc">PMC7195984</ArticleId><ArticleId IdType="pubmed">32299202</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra PS Edwards TG Xu B Jain M &amp; Kalra SP. The anti-gonadotropic effects of cytokines: the role of neuropeptides. Domestic Animal Endocrinology 199815321&#x2013;332. (10.1016/s0739-7240(9800030-7)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0739-7240(9800030-7</ArticleId><ArticleId IdType="pubmed">9785036</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Sarchielli E, Comeglio P, Filippi S, Vignozzi L, Marini M, Rastrelli G, Maneschi E, Cellai I, Persani L, et al.Metabolic syndrome induces inflammation and impairs gonadotropin-releasing hormone neurons in the preoptic area of the hypothalamus in rabbits. Molecular and Cellular Endocrinology 2014382107&#x2013;119. (10.1016/j.mce.2013.09.017)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2013.09.017</ArticleId><ArticleId IdType="pubmed">24064031</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>